Indole-based Novel Molecule as Preventive against COVID Variants
Recently, a team of researchers from India and Paris has developed a novel molecule that has shown promise in lab tests as a potential preventive against the variants of the SARS-CoV-2 virus.
Key Points
- The compounds are based on indole which are ubiquitous molecules found in some amino acids and natural alkaloids.
- The current molecules are designed to treat the acute and long-term symptoms of COVID-19.
- They are first in class molecules displaying the original property of targeting not only one but several molecular targets involved in COVID-19.
- Due to its multi-target properties, the compounds interfere with several stages of SARS-CoV-2 infection, including ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 AI Index 2025
- 2 Green Ammonia
- 3 Orbiting Carbon Observatories
- 4 Satellite Internet
- 5 ‘Agnishodh’ Research Cell at IIT Madras
- 6 AI-Designed Proteins to Boost Immunity
- 7 NASA Unveils Surya AI Model to Decode Sun’s Behaviour
- 8 NASA’s Lunar Nuclear Reactor Plan
- 9 India’s First Indigenous Commercial EO Constellation
- 10 WHO Declares Hepatitis D as Carcinogenic
